References:
1. Confavreux C, Vukusic S (2006)
Accumulation of irreversible disability in multiple sclerosis: from
epidemiology to treatment. Clinical neurology and neurosurgery 108
(3):327-332. doi:10.1016/j.clineuro.2005.11.018
2. Herrmann MM, Barth S, Greve B,
Schumann KM, Bartels A, Weissert R (2016) Identification of gene
expression patterns crucially involved in experimental autoimmune
encephalomyelitis and multiple sclerosis. Disease models & mechanisms 9
(10):1211-1220. doi:10.1242/dmm.025536
3. Vartzelis G, Maritsi D, Nikolaidou
M, Garoufi A, Kilidireas C (2019) Rituximab as Rescue Therapy for
Aggressive Pediatric Multiple Sclerosis. Case reports in pediatrics
2019:8731613. doi:10.1155/2019/8731613
4. Kucukali CI, Kurtuncu M, Coban A,
Cebi M, Tuzun E (2015) Epigenetics of multiple sclerosis: an updated
review. Neuromolecular medicine 17 (2):83-96.
doi:10.1007/s12017-014-8298-6
5. Chu F, Shi M, Lang Y, Shen D, Jin
T, Zhu J, Cui L (2018) Gut Microbiota in Multiple Sclerosis and
Experimental Autoimmune Encephalomyelitis: Current Applications and
Future Perspectives. Mediators of inflammation 2018:8168717.
doi:10.1155/2018/8168717
6. Waubant E, Lucas R, Mowry E, Graves
J, Olsson T, Alfredsson L, Langer-Gould A (2019) Environmental and
genetic risk factors for MS: an integrated review. Annals of clinical
and translational neurology 6 (9):1905-1922. doi:10.1002/acn3.50862
7. Rawji KS, Yong VW (2013) The
benefits and detriments of macrophages/microglia in models of multiple
sclerosis. Clinical & developmental immunology 2013:948976.
doi:10.1155/2013/948976
8. Aguzzi A, Barres BA, Bennett ML
(2013) Microglia: scapegoat, saboteur, or something else? Science 339
(6116):156-161. doi:10.1126/science.1227901
9. Vogel DY, Vereyken EJ, Glim JE,
Heijnen PD, Moeton M, van der Valk P, Amor S, Teunissen CE, van Horssen
J, Dijkstra CD (2013) Macrophages in inflammatory multiple sclerosis
lesions have an intermediate activation status. J Neuroinflammation
10:35. doi:10.1186/1742-2094-10-35
10. Sica A, Mantovani A (2012)
Macrophage plasticity and polarization: in vivo veritas. The Journal of
clinical investigation 122 (3):787-795. doi:10.1172/JCI59643
11. Mantovani A, Sica A, Locati M
(2005) Macrophage polarization comes of age. Immunity 23 (4):344-346.
doi:10.1016/j.immuni.2005.10.001
12. Mikita J, Dubourdieu-Cassagno N,
Deloire MS, Vekris A, Biran M, Raffard G, Brochet B, Canron MH, Franconi
JM, Boiziau C, Petry KG (2011) Altered M1/M2 activation patterns of
monocytes in severe relapsing experimental rat model of multiple
sclerosis. Amelioration of clinical status by M2 activated monocyte
administration. Multiple sclerosis 17 (1):2-15.
doi:10.1177/1352458510379243
13. Zhang XM, Lund H, Mia S, Parsa R,
Harris RA (2014) Adoptive transfer of cytokine-induced immunomodulatory
adult microglia attenuates experimental autoimmune encephalomyelitis in
DBA/1 mice. Glia 62 (5):804-817. doi:10.1002/glia.22643
14. Kobashi S, Terashima T, Katagi M,
Nakae Y, Okano J, Suzuki Y, Urushitani M, Kojima H (2019)
Transplantation of M2-Deviated Microglia Promotes Recovery of Motor
Function after Spinal Cord Injury in Mice. Molecular therapy : the
journal of the American Society of Gene Therapy.
doi:10.1016/j.ymthe.2019.09.004
15. Blackwell TS, Christman JW (1997)
The Role of Nuclear Factor- κ B in Cytokine Gene Regulation. Am J Respir
Cell Mol Biol 17 (1):3-9
16. Liu ZG, Hsu H, Goeddel DV, Karin
M (1996) Dissection of TNF Receptor 1 Effector Functions: JNK Activation
Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death.
Cell 87 (3):565-576
17. Denk A, Wirth T, Baumann B (2000)
NF-kappaB transcription factors: critical regulators of hematopoiesis
and neuronal survival. Cytokine & Growth Factor Reviews 11 (4):303-320
18. Pahan K, Schmid M (2000)
Activation of nuclear factor-kB in the spinal cord of experimental
allergic encephalomyelitis. Neuroscience Letters 287 (1):17-20
19. Mori N, Yamada Y, Ikeda S,
Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M
(2002) Bay 11-7082 inhibits transcription factor NF-kappaB and induces
apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell
leukemia cells. Blood 100 (5):1828-1834. doi:10.1182/blood-2002-01-0151
20. Xie Z, Chen J, Zheng C, Wu J,
Cheng Y, Zhu S, Lin C, Cao Q, Zhu J, Jin T (2017) 1,25-dihydroxyvitamin
D3 -induced dendritic cells suppress experimental autoimmune
encephalomyelitis by increasing proportions of the regulatory
lymphocytes and reducing T helper type 1 and type 17 cells. Immunology
152 (3):414-424. doi:10.1111/imm.12776
21. Huang WJ, Chen WW, Zhang X (2017)
Multiple sclerosis: Pathology, diagnosis and treatments. Experimental
and therapeutic medicine 13 (6):3163-3166. doi:10.3892/etm.2017.4410
22. Banerjee S, Cui H, Xie N, Tan Z,
Yang S, Icyuz M, Thannickal VJ, Abraham E, Liu G (2013) miR-125a-5p
regulates differential activation of macrophages and inflammation. The
Journal of biological chemistry 288 (49):35428-35436.
doi:10.1074/jbc.M112.426866
23. Malyshev I, Malyshev Y (2015)
Current Concept and Update of the Macrophage Plasticity Concept:
Intracellular Mechanisms of Reprogramming and M3 Macrophage ”Switch”
Phenotype. BioMed research international 2015:341308.
doi:10.1155/2015/341308
24. Almolda B, Gonzalez B, Castellano
B (2011) Antigen presentation in EAE: role of microglia, macrophages and
dendritic cells. Frontiers in bioscience 16:1157-1171
25. Jiang HR, Milovanovic M, Allan D,
Niedbala W, Besnard AG, Fukada SY, Alves-Filho JC, Togbe D, Goodyear CS,
Linington C, Xu D, Lukic ML, Liew FY (2012) IL-33 attenuates EAE by
suppressing IL-17 and IFN-gamma production and inducing alternatively
activated macrophages. European journal of immunology 42 (7):1804-1814.
doi:10.1002/eji.201141947
26. Liu C, Li Y, Yu J, Feng L, Hou S,
Liu Y, Guo M, Xie Y, Meng J, Zhang H, Xiao B, Ma C (2013) Targeting the
shift from M1 to M2 macrophages in experimental autoimmune
encephalomyelitis mice treated with fasudil. PloS one 8 (2):e54841.
doi:10.1371/journal.pone.0054841
27. Poggi A, Zocchi MR, Costa P,
Ferrero E, Borsellino G, Placido R, Galgani S, Salvetti M, Gasperini C,
Ristori G (1999) IL-12-mediated NKRP1A up-regulation and consequent
enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+
T lymphocytes from healthy donors and multiple sclerosis patients.
Journal of immunology 162 (7):4349-4354
28. Airas L (2015) Hormonal and
gender-related immune changes in multiple sclerosis. Acta neurologica
Scandinavica 132 (199):62-70. doi:10.1111/ane.12433
29. Blonda M, Amoruso A, Grasso R, Di
Francescantonio V, Avolio C (2017) Multiple Sclerosis Treatments Affect
Monocyte-Derived Microvesicle Production. Frontiers in neurology 8:422.
doi:10.3389/fneur.2017.00422
30. Luo C, Jian C, Liao Y, Huang Q,
Wu Y, Liu X, Zou D, Wu Y (2017) The role of microglia in multiple
sclerosis. Neuropsychiatric disease and treatment 13:1661-1667.
doi:10.2147/NDT.S140634
31. Subramaniam SR, Federoff HJ
(2017) Targeting Microglial Activation States as a Therapeutic Avenue in
Parkinson’s Disease. Frontiers in aging neuroscience 9:176.
doi:10.3389/fnagi.2017.00176
32. Vogel DYS (2015-02-20) Macrophage
Microglia Plasticity in Multiple Sclerosis.
33. Parsa R, Andresen P, Gillett A,
Mia S, Zhang XM, Mayans S, Holmberg D, Harris RA (2012) Adoptive
transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in
NOD mice. Diabetes 61 (11):2881-2892. doi:10.2337/db11-1635
34. Wang Y, Wang YP, Zheng G, Lee VW,
Ouyang L, Chang DH, Mahajan D, Coombs J, Wang YM, Alexander SI, Harris
DC (2007) Ex vivo programmed macrophages ameliorate experimental chronic
inflammatory renal disease. Kidney international 72 (3):290-299.
doi:10.1038/sj.ki.5002275
35. Hilliard B, Samoilova EB, Liu TS,
Rostami A, Chen Y (1999) Experimental autoimmune encephalomyelitis in
NF-kappa B-deficient mice:roles of NF-kappa B in the activation and
differentiation of autoreactive T cells. Journal of immunology 163
(5):2937-2943
36. Qin H, Wilson CA, Lee SJ, Zhao X,
Benveniste EN (2005) LPS induces CD40 gene expression through the
activation of NF-κB and STAT-1α in macrophages and microglia. Blood 106
(9):3114-3122. doi:10.1182/blood-2005-02-0759
37. Zhang XM, Zheng XY, Sharkawi SS,
Ruan Y, Amir N, Azimullah S, Hasan MY, Zhu J, Adem A (2013) Possible
protecting role of TNF-alpha in kainic acid-induced neurotoxicity via
down-regulation of NFkappaB signaling pathway. Curr Alzheimer Res 10
(6):660-669. doi:10.2174/15672050113109990007